Top Markets
Coin of the day
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
Rang in Aktien #19935
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Aktienkurs
$5.22
Marktkapitalisierung
$146.14M
Veränderung (1 Tag)
-1.35%
Veränderung (1 Jahr)
-32.16%
Land
BE
Handel Hyloris Pharmaceuticals S.A. (HYL)

Kategorie

Aktien-Split-Historie für Hyloris Pharmaceuticals S.A. (HYL)
Die Aktie Hyloris Pharmaceuticals S.A. (Symbol: HYL) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 25, 2026 statt.
Eine HYL-Aktie, die vor dem Aug 25, 2026 gekauft wurde, entspricht heute 0 HYL-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH